|Home | About | Journals | Submit | Contact Us | Français|
Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
A network of cortical brain regions including the insula and anterior cingulate cortex (ACC) has been proposed as the critical and sole substrate for interoceptive awareness. Combining lesion and pharmacological approaches in humans, we found the insula and ACC are not critical for awareness of heartbeat sensations. Rather, both somatosensory afferents from the skin and a network including the insula and ACC mediate it. Together these pathways enable the core human experience of the cardiovascular state of the body.
Recent functional neuroimaging studies have highlighted a network of brain regions including the insula and the ACC as important for representing the visceral state of the body, since they are activated when we feel interoceptive stimuli such as the heartbeat1–3 and gastrointestinal sensations4. The insula has been proposed as the sole and critical cortical substrate for interoceptive awareness5,6, while the ACC has been suggested to play a visceromotor role2,5. It has been further proposed that the anterior insula “instantiates all subjective feelings from the body and feelings of emotion”5,6. Under this view, in the complete absence of the insula, interoceptive awareness would be fully absent.
However, the same studies supporting a role for the insula and ACC also show that interoceptive stimuli robustly activate somatosensory cortices1–4. The experience of our skin blushing during embarrassment, or the feeling of our heart pounding in the chest, and of blood vessels pulsating in the throat during anxiety and fear, intuitively suggests that perhaps the skin and its somatosensory afferent projections may also critically contribute to interoceptive awareness and emotion7–9. Under this view, the insula (and ACC) would not be necessary for interoceptive awareness, and, in addition to “interoceptive” pathways projecting to the insula, other somatosensory pathways would play a role10.
We thus considered two possible interoceptive awareness “pathways”7,9: one involving visceral afferents projecting to the insula, and another involving skin afferents projecting to somatosensory cortex (see Fig. 1 for specific alternative hypotheses). We examined the contributions of these two pathways to interoception in a patient (Roger) with virtually complete bilateral insula and ACC damage, but intact bilateral primary somatosensory cortex11 (Fig. 2). Roger's neurological presentation is extremely rare and represented a unique opportunity to test, in humans, predictions about these pathways.
We assessed moment-to-moment awareness of cardiovascular sensations in response to bolus administration of isoproterenol, a sympathetic (beta adrenergic) agonist similar to adrenaline, as a marker of interoceptive awareness8 (Supplementary Methods). After each bolus participants turned a dial to track their moment-to-moment experience of the intensity of heartbeat sensations. All participants provided informed written consent as approved by the General Clinical Research Center Advisory Committee and the Institutional Review Board of the University of Iowa prior to participation.
As expected, Roger demonstrated dose-dependent heart rate increases indistinguishable from healthy comparison participants (Fig. 3a and Supplementary Table 1). However, contrary to what would be predicted based on H1 or H4 (Fig. 1), Roger demonstrated dose-dependent changes in interoceptive awareness comparable to healthy comparison participants, albeit, somewhat delayed in time (Fig. 3b and Supplementary Fig. 1b). Verbal responses recorded during the experimental session also suggested that Roger perceived qualitative changes in cardiovascular sensation (Supplementary Table 2). This suggested that the insula and ACC were not necessary for interoceptive awareness and that H2 or H3 should be true.
To further assess these two remaining hypotheses, we applied a topical lidocaine anesthetic to the skin covering each participant's region of maximal heartbeat sensation, as reported during the previous isoproterenol challenge (Fig. 3c). We then repeated a new challenge with the highest doses (details in Supplementary Methods). Roger again demonstrated heart rate increases identical to healthy comparison participants (Supplementary Fig. 2a). However, under anesthetic he no longer reported any changes in cardiac sensation (Fig. 3d). Verbal responses further suggested that Roger failed to experience any qualitative changes in awareness (Supplementary Table 3). On the other hand, sensation in healthy comparison participants was unaffected by anesthetic. Quantitative sensory testing demonstrated a satisfactory anesthetic effect in all participants.
Taken together, these results support the hypothesis (H3) that both neural structures innervating the skin, presumably involving primary and secondary somatosensory cortices, and the network of regions damaged in our patient, including the insula and ACC, independently mediate the ability to feel the heartbeat. These results also suggest that the insula is not the sole necessary substrate for interoceptive awareness. This study represents the first empirical demonstration of this concept7,9,12,13. Although it would have served to further test these hypotheses, it was not possible to include a patient with complete bilateral somatosensory cortex damage. This type of damage is highly implausible, and we have never encountered such an individual.
The precise contribution of the two “pathways” remains to be determined, not only for their link to interoceptive awareness but also in regard to their role in the experience of emotion5,7,9,14,15. It is possible that each pathway contributes to different aspects of interoception. For instance, the observed delay in Roger's ratings is compatible with a role for the insula in the online, instantaneous representation of the state of the body in time6. It is important to note that beyond the insula Roger also has bilateral damage to the ACC, orbitofrontal cortices, basal forebrain, hippocampus, amygdala, and temporal poles11. While the insula is typically considered as the key structure relevant for visceral sensation, the ACC is thought to play a visceral motor role, and therefore, is not expected to be critical for awareness2,6. The remaining structures are less often implicated in interoceptive awareness. We cannot rule out however that the damage incurred to these regions played a significant role in the present findings.
This lesion study challenges classic definitions of what constitutes interoception, validates functional neuroimaging findings that implicate both brain regions (insula and ACC) and somatosensory cortices in interoceptive awareness1–4, and demonstrates the set of pathways that enable the core human experience of the cardiovascular state of the body. Our findings provide empirical support for a comprehensive redefinition of interoception involving “afferent information that arises from anywhere and everywhere within the body”14, including through the skin via pathways usually considered to support exteroception. Such redefinition focuses on the source of stimulation within the body, and not on the intrinsic nature of the sensory pathway5,7,9,14. Additional investigations in the same patient are underway to determine whether these findings generalize to different interoceptive stimuli, and will be the subject of future reports.
Joel Bruss for figure assistance, Sonia Schubert and Michael Bosch for isoproterenol administration, Chirag Sandesara, Erik St. Louis, Brian Olshansky and HyungSub Shim for medical supervision, Thomas Grabowski for neurological expertise, and James Martins for safety monitoring. Supported by US National Center for Complementary & Alternative Medicine grant F31-AT003061, US National Institute on Drug Abuse grant R01-DA022549, and US National Center for Research Resources, General Clinical Research Center Program M01-RR-59.